Open AccessSustained improvement of dyslipidaemia in HAART-treated patients replacing stavudine with tenofovir
Author(s) -
Josep M. Llibre,
Peré Domingo,
Rosario Palacios,
Jesús Santos,
María Jesús PérezElías,
Rainel Sánchez-de la Rosa,
Celia Miralles,
Antonio Antela,
Santiago Moreno
Publication year - 2006
Publication title -
aids
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.195
H-Index - 216
eISSN - 1473-5571
pISSN - 0269-9370
DOI - 10.1097/01.aids.0000233574.49220.de
Subject(s) - stavudine , medicine , adverse effect , lipid profile , cholesterol , gastroenterology , prospective cohort study , human immunodeficiency virus (hiv) , endocrinology , viral load , antiretroviral therapy , immunology
To describe the 12-month evolution of lipid profile in HIV-infected virologically suppressed patients substituting tenofovir for stavudine.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom